FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W170227579> ?p ?o ?g. }

• W170227579 endingPage "998" @default.
• W170227579 startingPage "992" @default.
• W170227579 abstract "Hextend[registered sign] (BioTime, Inc., Berkeley, CA) is a new plasma volume expander containing 6% hetastarch, balanced electrolytes, a lactate buffer, and physiological levels of glucose. In preclinical studies, its use in shock models was associated with an improvement in outcome compared with alternatives, such as albumin or 6% hetastarch in saline. In a prospective, randomized, two-center study (n = 120), we compared the efficacy and safety of Hextend[registered sign] versus 6% hetastarch in saline (HES) for the treatment of hypovolemia during major surgery. Patients at one center had a blood sample drawn at the beginning and the end of surgery for thromboelastographic (TEG) analysis. Hextend[registered sign] was as effective as HES for the treatment of hypovolemia. Patients received an average of 1596 mL of Hextend[registered sign]: 42% received >20 mL/kg up to a total of 5000 mL. No patient received albumin. Hextend[registered sign]-treated patients required less intraoperative calcium (4 vs 220 mg; P < 0.05). In a subset analysis of patients receiving red blood cell transfusions (n = 56; 47%), Hextend[registered sign]-treated patients had a lower mean estimated blood loss (956 mL less; P = 0.02) and were less likely to receive calcium supplementation (P = 0.04). Patients receiving HES demonstrated significant prolongation of time to onset of clot formation (based on TEG) not seen in the Hextend[registered sign] patients (P < 0.05). No Hextend[registered sign] patient experienced a related serious adverse event, and there was no difference in the total number of adverse events between the two groups. The results of this study demonstrate that Hextend[registered sign], with its novel buffered, balanced electrolyte formulation, is as effective as 6% hetastarch in saline for the treatment of hypovolemia and may be a safe alternative even when used in volumes up to 5 L. Implications: Hextend[registered sign] (BioTime, Inc., Berkeley, CA) is a new plasma volume expander containing 6% hetastarch, balanced electrolytes, a lactate buffer, and a physiological level of glucose. It is as effective as 6% hetastarch in saline for the treatment of hypovolemia but has a more favorable side effects profile in volumes of up to 5 L compared with 6% hetastarch in saline. (Anesth Analg 1999;88:992-8)" @default.
• W170227579 created "2016-06-24" @default.
• W170227579 creator A5000071467 @default.
• W170227579 creator A5004445978 @default.
• W170227579 creator A5016859613 @default.
• W170227579 creator A5019646762 @default.
• W170227579 creator A5030422565 @default.
• W170227579 creator A5041446171 @default.
• W170227579 creator A5046018289 @default.
• W170227579 creator A5068957802 @default.
• W170227579 creator A5075088264 @default.
• W170227579 creator A5079075207 @default.
• W170227579 creator A5088652167 @default.
• W170227579 date "1999-05-01" @default.
• W170227579 modified "2023-10-17" @default.
• W170227579 title "Hextend[registered sign], a Physiologically Balanced Plasma Expander for Large Volume Use in Major Surgery" @default.
• W170227579 cites W1456624770 @default.
• W170227579 cites W1554783366 @default.
• W170227579 cites W1964870440 @default.
• W170227579 cites W1971006323 @default.
• W170227579 cites W1987421741 @default.
• W170227579 cites W1992268079 @default.
• W170227579 cites W2053130694 @default.
• W170227579 cites W2059813008 @default.
• W170227579 cites W207151245 @default.
• W170227579 cites W2073316889 @default.
• W170227579 cites W2092765929 @default.
• W170227579 cites W2103413142 @default.
• W170227579 cites W2109951512 @default.
• W170227579 cites W2139724899 @default.
• W170227579 cites W2170665477 @default.
• W170227579 cites W4237079765 @default.
• W170227579 cites W4249090215 @default.
• W170227579 doi "https://doi.org/10.1097/00000539-199905000-00005" @default.
• W170227579 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10320157" @default.
• W170227579 hasPublicationYear "1999" @default.
• W170227579 type Work @default.
• W170227579 sameAs 170227579 @default.
• W170227579 citedByCount "78" @default.
• W170227579 countsByYear W1702275792012 @default.
• W170227579 countsByYear W1702275792014 @default.
• W170227579 countsByYear W1702275792015 @default.
• W170227579 countsByYear W1702275792016 @default.
• W170227579 countsByYear W1702275792017 @default.
• W170227579 countsByYear W1702275792018 @default.
• W170227579 crossrefType "journal-article" @default.
• W170227579 hasAuthorship W170227579A5000071467 @default.
• W170227579 hasAuthorship W170227579A5004445978 @default.
• W170227579 hasAuthorship W170227579A5016859613 @default.
• W170227579 hasAuthorship W170227579A5019646762 @default.
• W170227579 hasAuthorship W170227579A5030422565 @default.
• W170227579 hasAuthorship W170227579A5041446171 @default.
• W170227579 hasAuthorship W170227579A5046018289 @default.
• W170227579 hasAuthorship W170227579A5068957802 @default.
• W170227579 hasAuthorship W170227579A5075088264 @default.
• W170227579 hasAuthorship W170227579A5079075207 @default.
• W170227579 hasAuthorship W170227579A5088652167 @default.
• W170227579 hasBestOaLocation W1702275791 @default.
• W170227579 hasConcept C126322002 @default.
• W170227579 hasConcept C141071460 @default.
• W170227579 hasConcept C2776125364 @default.
• W170227579 hasConcept C2777397205 @default.
• W170227579 hasConcept C2778165595 @default.
• W170227579 hasConcept C2781309813 @default.
• W170227579 hasConcept C2909252273 @default.
• W170227579 hasConcept C37557685 @default.
• W170227579 hasConcept C42219234 @default.
• W170227579 hasConcept C71924100 @default.
• W170227579 hasConceptScore W170227579C126322002 @default.
• W170227579 hasConceptScore W170227579C141071460 @default.
• W170227579 hasConceptScore W170227579C2776125364 @default.
• W170227579 hasConceptScore W170227579C2777397205 @default.
• W170227579 hasConceptScore W170227579C2778165595 @default.
• W170227579 hasConceptScore W170227579C2781309813 @default.
• W170227579 hasConceptScore W170227579C2909252273 @default.
• W170227579 hasConceptScore W170227579C37557685 @default.
• W170227579 hasConceptScore W170227579C42219234 @default.
• W170227579 hasConceptScore W170227579C71924100 @default.
• W170227579 hasIssue "5" @default.
• W170227579 hasLocation W1702275791 @default.
• W170227579 hasLocation W1702275792 @default.
• W170227579 hasLocation W1702275793 @default.
• W170227579 hasOpenAccess W170227579 @default.
• W170227579 hasPrimaryLocation W1702275791 @default.
• W170227579 hasRelatedWork W1541936478 @default.
• W170227579 hasRelatedWork W2014768598 @default.
• W170227579 hasRelatedWork W2018097748 @default.
• W170227579 hasRelatedWork W2023364661 @default.
• W170227579 hasRelatedWork W2031469729 @default.
• W170227579 hasRelatedWork W2057881500 @default.
• W170227579 hasRelatedWork W2091604258 @default.
• W170227579 hasRelatedWork W2097033056 @default.
• W170227579 hasRelatedWork W2116255741 @default.
• W170227579 hasRelatedWork W2256847737 @default.
• W170227579 hasVolume "88" @default.
• W170227579 isParatext "false" @default.
• W170227579 isRetracted "false" @default.
• W170227579 magId "170227579" @default.

• next